Literature DB >> 8904314

Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene.

S A Harris1, K R Tau, R J Enger, D O Toft, B L Riggs, T C Spelsberg.   

Abstract

The gene coding for the human wild-type estrogen receptor (ER) was stably transfected into the human fetal osteoblastic cell line hFOB 1.19, a clonal cell line which is conditionally immortilized with a temperature sensitive mutant of SV40 large T antigen (tsA58). Five subclones were obtained which express various levels of ER mRNA and protein. The subclone with the highest level of functional (nuclear bound) ER, hFOB/ER9, contained 3,931 (+/- 1,341) 17beta-estradiol molecules bound/nucleus as determined by the nuclear binding (NB) assay. Using the dextran coated charcoal (DCC) method, the level of total cytosolic ER measured was 204 (+/- 2) fmol/mg protein. This subclone was examined further for estradiol (E2) responsiveness. The ER expressed in hFOB/ER9 cells was shown to be functional using a transiently transfected ERE-TK-luciferase construct. Expression of luciferase from this construct increased approximately 25-fold in hFOB/ER9 cells following 10(-9)M E2 treatment. This effect on ERE-TK-luciferase expression was both dose and steroid dependant. Further, treatment of hFOB/ER9 cells with 10(-9)M E2 resulted in a 2.5-4.0-fold increase in endogenous progesterone receptor (PR) levels detected by steroid binding assays, and a noticeable increase in both the A and B forms of PR by western blot assay. The establishment of this estrogen responsive human osteoblastic cell line should provide an excellent model system for the study of estrogen action on osteoblast function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8904314     DOI: 10.1002/jcb.240590209

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.

Authors:  Ashok Kumar; Ming Ruan; Kari Clifton; Farhan Syed; Sundeep Khosla; Merry Jo Oursler
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

2.  Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics.

Authors:  Mohan Liu; Paul E Goss; James N Ingle; Michiaki Kubo; Yoichi Furukawa; Anthony Batzler; Gregory D Jenkins; Erin E Carlson; Yusuke Nakamura; Daniel J Schaid; Judy-Anne W Chapman; Lois E Shepherd; Matthew J Ellis; Sundeep Khosla; Liewei Wang; Richard M Weinshilboum
Journal:  Mol Endocrinol       Date:  2014-08-22

3.  Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.

Authors:  Venugopal Thayanithy; Aaron L Sarver; Reena V Kartha; Lihua Li; Andrea Y Angstadt; Matthew Breen; Clifford J Steer; Jaime F Modiano; Subbaya Subramanian
Journal:  Bone       Date:  2011-10-18       Impact factor: 4.398

4.  Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures.

Authors:  C Méndez-Dávila; C García-Moreno; C Turbì; C de la Piedra
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

5.  Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen.

Authors:  D J Rickard; L C Hofbauer; S K Bonde; F Gori; T C Spelsberg; B L Riggs
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

6.  Hydrogel-mediated DNA delivery confers estrogenic response in nonresponsive osteoblast cells.

Authors:  M Dadsetan; J P Szatkowski; K L Shogren; M J Yaszemski; A Maran
Journal:  J Biomed Mater Res A       Date:  2009-12-15       Impact factor: 4.396

7.  O-Fucose and Fringe-modified NOTCH1 extracellular domain fragments as decoys to release niche-lodged hematopoietic progenitor cells.

Authors:  Shuiliang Yu; Weihuan Wang; Marwah Albakri; Xiaoxing Yu; Gurnoor Majihail; Seunghwan Lim; Rachel K Lopilato; Atsuko Ito; John Letterio; Robert S Haltiwanger; Lan Zhou
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

8.  The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton.

Authors:  Anne Gingery; Malayannan Subramaniam; Kevin S Pitel; Jordan M Reese; Muzaffer Cicek; Laurence B Lindenmaier; James N Ingle; Matthew P Goetz; Russell T Turner; Urszula T Iwaniec; Thomas C Spelsberg; John R Hawse
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

9.  Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.

Authors:  Alessio Danilo Inchingolo; Angelo Michele Inchingolo; Giuseppina Malcangi; Pasquale Avantario; Daniela Azzollini; Silvio Buongiorno; Fabio Viapiano; Merigrazia Campanelli; Anna Maria Ciocia; Nicole De Leonardis; Elisabetta de Ruvo; Irene Ferrara; Grazia Garofoli; Valentina Montenegro; Anna Netti; Giulia Palmieri; Antonio Mancini; Assunta Patano; Fabio Piras; Grazia Marinelli; Chiara Di Pede; Claudia Laudadio; Biagio Rapone; Denisa Hazballa; Alberto Corriero; Maria Celeste Fatone; Andrea Palermo; Felice Lorusso; Antonio Scarano; Ioana Roxana Bordea; Daniela Di Venere; Francesco Inchingolo; Gianna Dipalma
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.